|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Chlamydia IgA (Pneumonia) ELISA | Amyloid Beta (N3pE) ELISA Assay | Anti-Certolizumab pegol (Cimzia®) ELISA | Complement System Screen ELISA Assay | IGF-1 ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB19215 | 27716 | TM09035 | COMPL 300 RUO | E20 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of IgA antibody to C. Pneumoniae in human serum or plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Amyloid ß (N3pE-42) in brain tissue extract. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay for the determination of free antibodies to Certolizumab pegol (CZP) in serum and plasma. For research use only, not for use in diagnostic procedures. | The Wieslab® Complement system Screen kit is an enzyme immunoassay for the determination of functional classical, MBL and alternative complement pathways in human serum. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of levels of IGF-I in serum or plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Chlamydia IgA (Pneumonia) | Anti-Trastuzumab (Herceptin®) | sAPP Beta-w | Human NfL (Neurofilament light chain) | Alpha-Klotho (Soluble) |
| Sample Type | Human serum or plasma. | Serum and plasma. | Blood Plasma, CSF, Cell Culture Supernatant | Cerebrospinal fluids | Serum, plasma (EDTA, Heparin, Citrate), urine and cell culture supernatant |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 1 calibrator used to calculate Antibody Index value (see 'Results' section of protocol). | 7.75 to 496 pg/mL | 0 / 30 - 1000 ng/mL | Inquire | 2 to 50 ng/mL |
| Sensitivity | Inquire | 30 ng/mL | 0.05 ng/mL | 10.2 pg/mL | 6.15 pg/mL |
| Assay Time | 20 min. incubation (RT) + 20 min. (RT) + 10 min. (RT) = 50 min. total incubation time. | Overnight + 1 hr 30 mins (incubation) | 2 hour, 45 min. total incubation time. | 2 hrs (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |